Annual Drug Patent Expirations for CAYSTON Cayston is a drug marketed by Gilead and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent expiration for Gilead drug CAYSTON appeared first on D…
VOTRIENT (pazopanib hydrochloride) Novartis Patent: 7,262,203 Expiration: Dec 19, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post …
Drug Patent Expirations for the Week of December 19, 2021 Read Post »
Annual Drug Patent Expirations for VOTRIENT Votrient is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Novartis drug VOTRIENT appeared fi…
New patent expiration for Novartis drug VOTRIENT Read Post »
Annual Drug Patent Expirations for VAZALORE Vazalore is a drug marketed by Plx Pharma and is included in one NDA. There are five patents protecting this drug. This drug has…
The post New patent expiration for Plx Pharma drug VAZALORE appeared first on …
New patent expiration for Plx Pharma drug VAZALORE Read Post »
Annual Drug Patent Expirations for BYSTOLIC Bystolic is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. There is one patent protecting…
The post New patent expiration for Allergan drug BYSTOLIC appeared fir…
New patent expiration for Allergan drug BYSTOLIC Read Post »
Annual Drug Patent Expirations for TEFLARO Teflaro is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are five patents protecting…
The post New patent expiration for Allergan drug TEFLARO appeared first …
OFIRMEV (acetaminophen) Mallinckrodt hosp Patent: 6,992,218 Expiration: Dec 6, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dru…
Drug Patent Expirations for the Week of December 5, 2021 Read Post »
Annual Drug Patent Expirations for OFIRMEV Ofirmev is a drug marketed by Mallinckrodt Hosp and is included in one NDA. It is available from two suppliers. There are five patents…
The post New patent expiration for Mallinckrodt Hosp drug OFIRMEV appeare…
New patent expiration for Mallinckrodt Hosp drug OFIRMEV Read Post »
Annual Drug Patent Expirations for SKELAXIN Skelaxin is a drug marketed by King Pharms and is included in one NDA. It is available from four suppliers. There are two patents…
The post New patent expiration for King Pharms drug SKELAXIN appeared first o…
New patent expiration for King Pharms drug SKELAXIN Read Post »
Annual Drug Patent Expirations for REQUIP+XL Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven…
The post New patent expiration for Glaxosmithkline Llc drug REQUIP XL app…
New patent expiration for Glaxosmithkline Llc drug REQUIP XL Read Post »